EvodiaBio ApS: Financial statements 2025
CVR: 42569283
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
EvodiaBio ApS (CVR 42569283) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -8,437,110 and a net result of DKK -26,798,122 compared with DKK -21,106,598 the year before. Equity in the 2025 report amounted to DKK 68,626,121. The solvency ratio was 76.8%. The company had 23 employees in the financial year.
- Gross Profit
- DKK -8,437,110
- Profit/Loss
- DKK -26,798,122
- Equity
- DKK 68,626,121
- Total Assets
- DKK 89,335,075
- Employees
- 23
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -8.4 mio. | -26.8 mio. | 68.6 mio. | 23 |
| 2024 | - | -10 mio. | -21.1 mio. | 52.4 mio. | 17 |
| 2023 | - | -9.9 mio. | -14.1 mio. | 23.6 mio. | 10 |
| 2022 | - | -2.9 mio. | -6.3 mio. | 37.7 mio. | 7 |
Official annual report
How creditworthy is EvodiaBio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 17, 2025, Jarne Elleholm is registered as an owner of EvodiaBio ApS with an ownership share of 5%.
As of December 17, 2025, FormanBiotech Holding ApS is registered as an owner of EvodiaBio ApS with an ownership share of 5%.
As of December 17, 2025, STARFISH BIO ApS is registered as an owner of EvodiaBio ApS with an ownership share of 5%.
As of December 17, 2025, SDBIO ApS is registered as an owner of EvodiaBio ApS with an ownership share of 5%.
As of December 17, 2025, Danmarks Eksport- og Investeringsfond is registered as an owner of EvodiaBio ApS with an ownership share of 10%.
As of December 17, 2025, is registered as an owner of EvodiaBio ApS with an ownership share of 15%.
As of December 9, 2025, Kyle Bjorn Teamey has joined the board of directors of EvodiaBio ApS.
As of December 9, 2025, Sotirios Kampranis has left the board of directors of EvodiaBio ApS.
As of December 9, 2025, Lauri Johannes Reuter has left the board of directors of EvodiaBio ApS.
As of July 31, 2025, Simon Louis Théodore Armand Dusséaux has stepped down as director of EvodiaBio ApS.
About EvodiaBio ApS
EvodiaBio ApS is a Danish company of the type Anpartsselskab based in Rødovre, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Camilla Benedicte Kloss Fenneberg. The board consists of Jarne Elleholm (chair), Andreas Helmut Fibig, Anne Françoise Véronique Cabotin and Flemming Besenbacher. The company's owners include Jarne Elleholm, BII Holdings A/S and FormanBiotech Holding ApS. According to the 2025 annual report, the company had an average of 23 employees. In 2025, the company reported a gross profit of DKK -8,437,110 and a net result of DKK -26,798,122 compared with DKK -21,106,598 the year before. Equity in the 2025 report amounted to DKK 68,626,121.